| Location: | London |
|---|---|
| Salary: | £39,187 to £52,790 per annum. |
| Hours: | Full Time |
| Contract Type: | Fixed-Term/Contract |
| Placed On: | 14th October 2026 |
|---|---|
| Closes: | 15th November 2026 |
| Job Ref: | 11480 |
About the Role
The post-holder will have responsibility to conduct laboratory experiments as outlined in the collaborative project funded by ARIA “epiPRIME epigenetically programmed resilience through innate memory engineering”. The project will employ epigenetic editing techniques engineered in cell lines and primary cells to induce antiviral immunity in human cells in vivo. The post-holder will work together with computational epigeneticists, immunologists and chemists to fulfil the aims of the project.
About You
You will have a PhD (or near to completion) in a biological subject, significant laboratory experience in molecular biology/biochemistry. Experience with cloning, working with cell lines and primary cells, transfections, RNA, (epi)genomics techniques (any of: targeted and WGBS/EM-seq, EPICarrays, CUT&RUN, CUT&Tag, ChIP-seq or similar techniques) and NGS library preparations is essential. You will have previously published in the epigenetics field as a first author and have a strong track record. Experience in R/Python will be a significant advantage.
About the School/Department/Institute/Project
The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed to supporting and developing future cancer researchers through its extensive postgraduate training.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Type / Role:
Subject Area(s):
Location(s):